With the popularity of semaglutide injectables came a growing drive to find a way to get the drugs effects in pill form
What makes this especially frustrating is that the people most affected by these contracts are often already stretched thin
The increased prevalence of these medications, alongside their physiological effects, underscores the need for clinicians to expect to see an increasing number of patients on these medications, even without diabetes, and be prepared to evaluate and manage the effects of GLP-1 RAs
When you decide to discontinue semaglutide, gradual tapering is preferable to sudden cessation
Lean mass loss can occur at any GLP-1 dose without resistance training and adequate protein intake
Using GLP-1 therapy and insulin safely together Safety depends largely on dose adjustments, monitoring and injecting at the right place to ensure consistent absorption